Article history: Received 21 January 2018 Received in revised form 26 January 2018 Accepted 31 January 2018 in PAF patients. In consequence, the presence of LVA predicted the recurrence of… Click to show full abstract
Article history: Received 21 January 2018 Received in revised form 26 January 2018 Accepted 31 January 2018 in PAF patients. In consequence, the presence of LVA predicted the recurrence of AF after PVI also in PAF patients. Therefore, the clinical presentation of AF does not always adequately mirror the progression of the underlying substrate and measures like LAV can help to assess the stage and the progression of atrial cardiomyopathy which can contribute critically to AF recurrence after PVI, irrespective of the clinical AF
               
Click one of the above tabs to view related content.